Cargando…

Expected Evolution of COVID-19 Epidemic in France for Several Combinations of Vaccination Strategies and Barrier Measures

The outbreak of the SARS-CoV-2 virus, enhanced by rapid spreads of variants, has caused a major international health crisis, with serious public health and economic consequences. An agent-based model was designed to simulate the evolution of the epidemic in France over 2021 and the first six months...

Descripción completa

Detalles Bibliográficos
Autores principales: Pageaud, Simon, Pothier, Catherine, Rigotti, Christophe, Eyraud-Loisel, Anne, Bertoglio, Jean-Pierre, Bienvenüe, Alexis, Leboisne, Nicolas, Ponthus, Nicolas, Gauchon, Romain, Gueyffier, François, Vanhems, Philippe, Iwaz, Jean, Loisel, Stéphane, Roy, Pascal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708137/
https://www.ncbi.nlm.nih.gov/pubmed/34960207
http://dx.doi.org/10.3390/vaccines9121462
_version_ 1784622608670523392
author Pageaud, Simon
Pothier, Catherine
Rigotti, Christophe
Eyraud-Loisel, Anne
Bertoglio, Jean-Pierre
Bienvenüe, Alexis
Leboisne, Nicolas
Ponthus, Nicolas
Gauchon, Romain
Gueyffier, François
Vanhems, Philippe
Iwaz, Jean
Loisel, Stéphane
Roy, Pascal
author_facet Pageaud, Simon
Pothier, Catherine
Rigotti, Christophe
Eyraud-Loisel, Anne
Bertoglio, Jean-Pierre
Bienvenüe, Alexis
Leboisne, Nicolas
Ponthus, Nicolas
Gauchon, Romain
Gueyffier, François
Vanhems, Philippe
Iwaz, Jean
Loisel, Stéphane
Roy, Pascal
author_sort Pageaud, Simon
collection PubMed
description The outbreak of the SARS-CoV-2 virus, enhanced by rapid spreads of variants, has caused a major international health crisis, with serious public health and economic consequences. An agent-based model was designed to simulate the evolution of the epidemic in France over 2021 and the first six months of 2022. The study compares the efficiencies of four theoretical vaccination campaigns (over 6, 9, 12, and 18 months), combined with various non-pharmaceutical interventions. In France, with the emergence of the Alpha variant, without vaccination and despite strict barrier measures, more than 600,000 deaths would be observed. An efficient vaccination campaign (i.e., total coverage of the French population) over six months would divide the death toll by 10. A vaccination campaign of 12, instead of 6, months would slightly increase the disease-related mortality (+6%) but require a 77% increase in ICU bed–days. A campaign over 18 months would increase the disease-related mortality by 17% and require a 244% increase in ICU bed–days. Thus, it seems mandatory to vaccinate the highest possible percentage of the population within 12, or better yet, 9 months. The race against the epidemic and virus variants is really a matter of vaccination strategy.
format Online
Article
Text
id pubmed-8708137
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87081372021-12-25 Expected Evolution of COVID-19 Epidemic in France for Several Combinations of Vaccination Strategies and Barrier Measures Pageaud, Simon Pothier, Catherine Rigotti, Christophe Eyraud-Loisel, Anne Bertoglio, Jean-Pierre Bienvenüe, Alexis Leboisne, Nicolas Ponthus, Nicolas Gauchon, Romain Gueyffier, François Vanhems, Philippe Iwaz, Jean Loisel, Stéphane Roy, Pascal Vaccines (Basel) Article The outbreak of the SARS-CoV-2 virus, enhanced by rapid spreads of variants, has caused a major international health crisis, with serious public health and economic consequences. An agent-based model was designed to simulate the evolution of the epidemic in France over 2021 and the first six months of 2022. The study compares the efficiencies of four theoretical vaccination campaigns (over 6, 9, 12, and 18 months), combined with various non-pharmaceutical interventions. In France, with the emergence of the Alpha variant, without vaccination and despite strict barrier measures, more than 600,000 deaths would be observed. An efficient vaccination campaign (i.e., total coverage of the French population) over six months would divide the death toll by 10. A vaccination campaign of 12, instead of 6, months would slightly increase the disease-related mortality (+6%) but require a 77% increase in ICU bed–days. A campaign over 18 months would increase the disease-related mortality by 17% and require a 244% increase in ICU bed–days. Thus, it seems mandatory to vaccinate the highest possible percentage of the population within 12, or better yet, 9 months. The race against the epidemic and virus variants is really a matter of vaccination strategy. MDPI 2021-12-10 /pmc/articles/PMC8708137/ /pubmed/34960207 http://dx.doi.org/10.3390/vaccines9121462 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Pageaud, Simon
Pothier, Catherine
Rigotti, Christophe
Eyraud-Loisel, Anne
Bertoglio, Jean-Pierre
Bienvenüe, Alexis
Leboisne, Nicolas
Ponthus, Nicolas
Gauchon, Romain
Gueyffier, François
Vanhems, Philippe
Iwaz, Jean
Loisel, Stéphane
Roy, Pascal
Expected Evolution of COVID-19 Epidemic in France for Several Combinations of Vaccination Strategies and Barrier Measures
title Expected Evolution of COVID-19 Epidemic in France for Several Combinations of Vaccination Strategies and Barrier Measures
title_full Expected Evolution of COVID-19 Epidemic in France for Several Combinations of Vaccination Strategies and Barrier Measures
title_fullStr Expected Evolution of COVID-19 Epidemic in France for Several Combinations of Vaccination Strategies and Barrier Measures
title_full_unstemmed Expected Evolution of COVID-19 Epidemic in France for Several Combinations of Vaccination Strategies and Barrier Measures
title_short Expected Evolution of COVID-19 Epidemic in France for Several Combinations of Vaccination Strategies and Barrier Measures
title_sort expected evolution of covid-19 epidemic in france for several combinations of vaccination strategies and barrier measures
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708137/
https://www.ncbi.nlm.nih.gov/pubmed/34960207
http://dx.doi.org/10.3390/vaccines9121462
work_keys_str_mv AT pageaudsimon expectedevolutionofcovid19epidemicinfranceforseveralcombinationsofvaccinationstrategiesandbarriermeasures
AT pothiercatherine expectedevolutionofcovid19epidemicinfranceforseveralcombinationsofvaccinationstrategiesandbarriermeasures
AT rigottichristophe expectedevolutionofcovid19epidemicinfranceforseveralcombinationsofvaccinationstrategiesandbarriermeasures
AT eyraudloiselanne expectedevolutionofcovid19epidemicinfranceforseveralcombinationsofvaccinationstrategiesandbarriermeasures
AT bertogliojeanpierre expectedevolutionofcovid19epidemicinfranceforseveralcombinationsofvaccinationstrategiesandbarriermeasures
AT bienvenuealexis expectedevolutionofcovid19epidemicinfranceforseveralcombinationsofvaccinationstrategiesandbarriermeasures
AT leboisnenicolas expectedevolutionofcovid19epidemicinfranceforseveralcombinationsofvaccinationstrategiesandbarriermeasures
AT ponthusnicolas expectedevolutionofcovid19epidemicinfranceforseveralcombinationsofvaccinationstrategiesandbarriermeasures
AT gauchonromain expectedevolutionofcovid19epidemicinfranceforseveralcombinationsofvaccinationstrategiesandbarriermeasures
AT gueyffierfrancois expectedevolutionofcovid19epidemicinfranceforseveralcombinationsofvaccinationstrategiesandbarriermeasures
AT vanhemsphilippe expectedevolutionofcovid19epidemicinfranceforseveralcombinationsofvaccinationstrategiesandbarriermeasures
AT iwazjean expectedevolutionofcovid19epidemicinfranceforseveralcombinationsofvaccinationstrategiesandbarriermeasures
AT loiselstephane expectedevolutionofcovid19epidemicinfranceforseveralcombinationsofvaccinationstrategiesandbarriermeasures
AT roypascal expectedevolutionofcovid19epidemicinfranceforseveralcombinationsofvaccinationstrategiesandbarriermeasures
AT expectedevolutionofcovid19epidemicinfranceforseveralcombinationsofvaccinationstrategiesandbarriermeasures